Header cover image
  • Investing Ideas
  • Taiwanese Pharmaceuticals & Biotech Large Cap High Growth Potential

Taiwanese Pharmaceuticals & Biotech Large Cap High Growth Potential

Results

1

1 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

1 companies

PharmaEssentia

Market Cap: NT$325.9b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

New

6446

NT$860.00

7D

7.8%

1Y

90.9%